-
Revenue
$-920.17K
Net Income
-
Gross Margin
-
Op. Margin
$-538.56K
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | - | - | $143.27K | $192.18K | $346.47K | $685.85K |
| Revenue Growth % | nan% | nan% | -25.4% | -44.5% | -49.5% | nan% |
| Cost of Revenue | - | - | $38.02K | $324.04K | $256.87K | $638.64K |
| Gross Profit | - | - | $105.25K | $-265.64K | $-602.55K | $47.21K |
| Gross Margin % | nan% | nan% | 73.5% | -138.2% | -173.9% | 6.9% |
| Operating Expenses | $1.07M | $1.07M | $1.10M | $1.37M | $2.32M | $2.40M |
| Research & Development | - | $2.19K | $6.23K | $101.41K | $203.75K | $308.82K |
| Operating Income | $-1.07M | $-1.07M | $-995.82K | $-1.63M | $-2.92M | $-2.36M |
| Operating Margin % | nan% | nan% | -695.1% | -850.7% | -843.2% | -343.5% |
| Other Income/Expense | $-45.23K | $-45.23K | $-90.94K | $-26.64K | $325.27K | $407.30K |
| Income Before Tax | - | $-1.12M | $-1.09M | - | - | - |
| Income Tax Expense | - | $-195.96K | $-124.37K | - | - | - |
| Net Income | $-920.17K | $-920.17K | $-962.38K | $-1.70M | $-2.66M | $-1.96M |
| Net Margin % | nan% | nan% | -671.7% | -882.8% | -768.8% | -286.3% |
| Basic EPS | nan | -0.02 | -0.02 | -0.03 | nan | nan |
| Diluted EPS | nan | -0.02 | -0.02 | -0.03 | nan | nan |
| Basic Shares Outstanding | - | 48.8M | 48.8M | 48.8M | - | - |
| Diluted Shares Outstanding | - | 48.8M | 48.8M | 48.8M | - | - |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $39.12K | $15.85K | $36.47K | $61.46K | $1.28M |
| Accounts Receivable | - | - | - | $7.72K | $1.48K |
| Inventory | - | - | - | $412.26K | $508.92K |
| Total Current Assets | $59.10K | $36.30K | $68.16K | $518.53K | $2.57M |
| Property Plant & Equipment | - | $28.65K | $42.97K | - | $76.93K |
| Goodwill | - | $773.16K | $1.31M | - | - |
| Total Assets | $59.10K | $838.12K | $1.42M | $1.89M | $4.07M |
| Total Current Liabilities | $518.17K | $181.06K | $3.35M | $967.11K | $608.71K |
| Deferred Tax Liabilities | - | - | - | - | $273.95K |
| Total Liabilities | $518.17K | $377.02K | $3.67M | $2.43M | $1.95M |
| Common Stock | $4.88K | $4.88K | $4.88K | $4.88K | $4.89K |
| Retained Earnings | $-12.68M | $-11.76M | $-10.80M | $-9.10M | $-6.44M |
| Treasury Stock | $119.40K | $119.40K | - | - | - |
| Total Stockholders Equity | $-459.07K | $461.10K | $-2.24M | $-545.38K | $2.12M |
| Total Liabilities & Equity | $59.10K | $838.12K | $1.42M | $1.89M | $4.07M |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $-920.17K | $-920.17K | $-962.38K | $-1.70M | $-2.66M | $-1.96M |
| Depreciation & Amortization | $21.48K | $10.74K | $14.32K | - | $25.64K | $9.85K |
| Stock-based Compensation | - | - | - | - | $7.84K | $15.62K |
| Deferred Income Tax | - | $-195.96K | $-124.37K | $34.95K | - | - |
| Change in Receivables | - | - | - | $-7.72K | $6.24K | $-118.58K |
| Change in Inventory | - | - | - | $-278.49K | $436.60K | $500.14K |
| Operating Cash Flow | $-538.56K | $-282.96K | $-289.55K | $-614.53K | $-1.90M | $-2.37M |
| Capital Expenditure | - | - | - | $42.97K | - | $31.93K |
| Investing Cash Flow | - | - | - | $-42.97K | - | $-31.93K |
| Stock Repurchased | - | - | - | - | $11.66K | - |
| Financing Cash Flow | $600.13K | $306.23K | $268.93K | $632.50K | $688.34K | $2.46M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | - | - | - | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | $64.46K | - | $241.69K | - |
| Research & Development | - | - | $125.00 | - |
| Operating Income | $-64.46K | - | $-241.69K | - |
| Interest Expense | - | - | - | - |
| Other Income/Expense | $-8.38K | - | $-18.76K | - |
| Income Tax Expense | - | - | - | - |
| Net Income | $-72.84K | $-124.01K | $-260.45K | - |
| Basic EPS | 0.00 | - | 0.00 | - |
| Diluted EPS | 0.00 | - | 0.00 | - |
| Basic Shares Outstanding | $48.83M | - | $48.83M | - |
| Diluted Shares Outstanding | $48.83M | - | $48.83M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $95.22K | $15.85K |
| Total Current Assets | $118.28K | $36.30K |
| Property Plant & Equipment | $17.90K | $28.65K |
| Goodwill | $773.16K | $773.16K |
| Total Assets | $909.35K | $838.12K |
| Total Current Liabilities | $512.75K | $181.06K |
| Total Liabilities | $708.70K | $377.02K |
| Common Stock | $4.88K | $4.88K |
| Retained Earnings | $-12.02M | $-11.76M |
| Treasury Stock | $119.40K | $119.40K |
| Total Stockholders Equity | $200.65K | $461.10K |
| Total Liabilities & Equity | $909.35K | $838.12K |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-72.84K | $-124.01K | $-260.45K | - |
| Depreciation & Amortization | - | - | $10.74K | - |
| Operating Cash Flow | - | - | $-226.89K | - |
| Financing Cash Flow | - | - | $306.23K | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.